Literature DB >> 2088527

Isolation and characterization of a macrophage-derived heparin-binding growth factor.

G Besner1, S Higashiyama, M Klagsbrun.   

Abstract

Human mononuclear cells were plated in culture, and the conditioned media of these cells were analyzed by heparin-Sepharose affinity chromatography. The fractions were tested for growth factor activity as measured by the stimulation of DNA synthesis in BALB/c 3T3 cells. After 2 d in culture, two peaks of heparin-binding growth factor (HBGF) activity were detected, one eluting with 0.5 M NaCl, which could be shown to be platelet-derived growth factor (PDGF)-like, and the other eluting with 1.0 M NaCl. After 7-11 d in culture, when monocytes had clearly differentiated into macrophages, greater than 95% of the HBGF activity in conditioned medium consisted of the 1.0 M NaCl elution peak. This activity, which was designated macrophage-derived HBGF (MD-HBGF), was found to be a cationic heat-resistant polypeptide with a molecular weight in the range of 14-25 kDa. Analysis using Western blots and specific neutralizing antisera, as well as comparative heparin affinity analysis, indicated that MD-HBGF was not identical to other heparin-binding 3T3 cell growth factors known to be produced by macrophages, such as PDGF (AB, AA, and BB forms), acidic fibroblast growth factor, and basic fibroblast growth factor. In addition to stimulating mitogenesis in 3T3 cells, MD-HBGF also stimulated the proliferation of vascular smooth muscle cells, but did not stimulate the proliferation of vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088527      PMCID: PMC362848          DOI: 10.1091/mbc.1.11.811

Source DB:  PubMed          Journal:  Cell Regul        ISSN: 1044-2030


  38 in total

1.  Heparin-binding angiogenesis factors: detection by immunological methods.

Authors:  M G Wadzinski; J Folkman; J Sasse; K Devey; D Ingber; M Klagsbrun
Journal:  Clin Physiol Biochem       Date:  1987

2.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  Inhibitory action of transforming growth factor beta on endothelial cells.

Authors:  G Müller; J Behrens; U Nussbaumer; P Böhlen; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Induction of transforming growth factor-alpha in activated human alveolar macrophages.

Authors:  D K Madtes; E W Raines; K S Sakariassen; R K Assoian; M B Sporn; G I Bell; R Ross
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

5.  Expression and secretion of type beta transforming growth factor by activated human macrophages.

Authors:  R K Assoian; B E Fleurdelys; H C Stevenson; P J Miller; D K Madtes; E W Raines; R Ross; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential.

Authors:  P Delli-Bovi; A M Curatola; K M Newman; Y Sato; D Moscatelli; R M Hewick; D B Rifkin; C Basilico
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

Review 7.  The fibroblast growth factor family: structural and biological properties.

Authors:  M Klagsbrun
Journal:  Prog Growth Factor Res       Date:  1989

8.  The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta.

Authors:  D J Hazuda; J C Lee; P R Young
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

9.  Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells.

Authors:  L Schweigerer; B Malerstein; D Gospodarowicz
Journal:  Biochem Biophys Res Commun       Date:  1987-03-30       Impact factor: 3.575

10.  Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.

Authors:  S D Wolpe; G Davatelis; B Sherry; B Beutler; D G Hesse; H T Nguyen; L L Moldawer; C F Nathan; S F Lowry; A Cerami
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  66 in total

1.  Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.

Authors:  Andrei Radulescu; Hong-Yi Zhang; Xiaoyi Yu; Jacob K Olson; Amanda K Darbyshire; Yan Chen; Gail E Besner
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

2.  Heparin-binding EGF-like growth factor protects pericytes from injury.

Authors:  Xiaoyi Yu; Andrei Radulescu; Chun-Liang Chen; Iyore O James; Gail E Besner
Journal:  J Surg Res       Date:  2010-09-17       Impact factor: 2.192

3.  Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model.

Authors:  Zhenyuan Li; Hao Yan; Jiangzi Yuan; Liou Cao; Aiwu Lin; Huili Dai; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  Clin Exp Nephrol       Date:  2017-07-14       Impact factor: 2.801

4.  Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.

Authors:  Chun-Liang Chen; Jixin Yang; Iyore O A James; Hong-Yi Zhang; Gail E Besner
Journal:  Surgery       Date:  2014-02-06       Impact factor: 3.982

5.  Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice.

Authors:  Jungsil Kim; Jesse D Procknow; Hiromi Yanagisawa; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

6.  M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.

Authors:  Jia Wei; Gail E Besner
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

7.  Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.

Authors:  Z Zhou; P A Harding
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

8.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.

Authors:  M Marikovsky; K Breuing; P Y Liu; E Eriksson; S Higashiyama; P Farber; J Abraham; M Klagsbrun
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes.

Authors:  T Nakano; E W Raines; J A Abraham; M Klagsbrun; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 10.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.